APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 46 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | -86.7% | 80,397 | -8.0% | 0.00% | – |
| Q4 2021 | $166,000 | +12.2% | 87,374 | +77.7% | 0.00% | – |
| Q3 2021 | $148,000 | +62.6% | 49,178 | +112.2% | 0.00% | – |
| Q2 2021 | $91,000 | +75.0% | 23,180 | +125.4% | 0.00% | – |
| Q1 2021 | $52,000 | -91.5% | 10,286 | -93.1% | 0.00% | -100.0% |
| Q4 2020 | $612,000 | +245.8% | 149,640 | +311.5% | 0.00% | +100.0% |
| Q3 2020 | $177,000 | -73.3% | 36,361 | -69.6% | 0.00% | -66.7% |
| Q2 2020 | $664,000 | +79.5% | 119,799 | +6.1% | 0.00% | 0.0% |
| Q1 2020 | $370,000 | +25.4% | 112,952 | +73.3% | 0.00% | +200.0% |
| Q4 2019 | $295,000 | +0.7% | 65,171 | -7.5% | 0.00% | 0.0% |
| Q3 2019 | $293,000 | -27.7% | 70,466 | -34.1% | 0.00% | 0.0% |
| Q2 2019 | $405,000 | -31.2% | 106,967 | -23.9% | 0.00% | -50.0% |
| Q1 2019 | $589,000 | +14.6% | 140,483 | -32.0% | 0.00% | 0.0% |
| Q4 2018 | $514,000 | -43.8% | 206,522 | +64.9% | 0.00% | 0.0% |
| Q3 2018 | $914,000 | +661.7% | 125,272 | +285.5% | 0.00% | – |
| Q2 2018 | $120,000 | -45.2% | 32,492 | -46.6% | 0.00% | -100.0% |
| Q4 2017 | $219,000 | +18.4% | 60,892 | +29.9% | 0.00% | 0.0% |
| Q3 2017 | $185,000 | +71.3% | 46,881 | +121.3% | 0.00% | – |
| Q2 2017 | $108,000 | -42.2% | 21,186 | +11.0% | 0.00% | -100.0% |
| Q3 2016 | $187,000 | -11.0% | 19,090 | +85.1% | 0.00% | 0.0% |
| Q4 2015 | $210,000 | – | 10,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|